Maxcyte (MXCT) Operating Margin (2020 - 2026)

Maxcyte (MXCT) reported Operating Margin of 64.09% for Q1 2026, up 15000.0% year-over-year from N/an in Q1 2025, and up 90.24% quarter-over-quarter from 656.3% in Q4 2025.

Maxcyte (MXCT) Operating Margin (2020 - 2026) Analysis & Trends

Maxcyte (MXCT) has 7 years of Operating Margin data on file, last reported at 64.09% in Q1 2026.

  • Operating Margin for Q1 2026 came in at 64.09%, up 15000.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.6% (up 1261.0% YoY), and the FY2025 annual result was 44.72%, down 2250.0% from the prior year.
  • Operating Margin rose to 64.09% in Q1 2026 per MXCT's latest filing, from 656.3% in the prior quarter.
  • Over five years, Operating Margin peaked at 341.8% in Q4 2024 and troughed at 656.3% in Q4 2025.
  • A 5-year average of 153.49% and a median of 172.13% in 2024 frame the typical range for Operating Margin.
  • The sharpest annual moves came in 2024 and 2025: Operating Margin surged 51203 bps in 2024, then slumped 99810 bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 218.48% in 2022, then plunged by 178 bps to 170.23% in 2023, then surged by 301 bps to 341.8% in 2024, then sank by 292 bps to 656.3% in 2025, then soared by 90 bps to 64.09% in 2026.
  • Business Quant data shows MXCT's Operating Margin at 64.09% in Q1 2026, 656.3% in Q4 2025, and 207.19% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Maxcyte 127.72 Mn 127.72 Mn 8.08 Mn -64.09%

Historic Data

Download Data
DateValue
Mar 31, 2026 -64.09%
Dec 31, 2025 -656.30%
Sep 30, 2025 -207.19%
Jun 30, 2025 -244.28%
Mar 31, 2025 -214.09%
Dec 31, 2024 341.80%
Sep 30, 2024 -172.13%
Jun 30, 2024 -241.10%
Mar 31, 2024 -219.82%
Dec 31, 2023 -170.23%
Sep 30, 2023 -335.71%
Jun 30, 2023 -144.56%
Mar 31, 2023 -265.47%
Dec 31, 2022 218.48%
Sep 30, 2022 -107.83%
Jun 30, 2022 -90.96%
Mar 31, 2022 -35.89%
Dec 31, 2021 228.28%
Sep 30, 2021 -43.56%
Jun 30, 2021 -62.14%